Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of ammonia in NAFLD: An unusual suspect
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein Kerbert, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100780-100780
Open Access | Times Cited: 23

Showing 23 citing articles:

The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis
María Mercado-Gómez, Naroa Goikoetxea‐Usandizaga, Annarein Kerbert, et al.
Metabolism (2024) Vol. 158, pp. 155952-155952
Closed Access | Times Cited: 6
Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength
Dana Crișan, Lucreţia Avram, Andreea Morariu-Barb, et al.
Nutrients (2025) Vol. 17, Iss. 1, pp. 178-178
Open Access
Nessler Histological Staining for Ammonia Detection in Formalin-Fixed Paraffin-Embedded (FFPE) Mammalian Tissue
Teresa C. Delgado, Javier de las Heras, Maria Luz Martínez‐Chantar
Neuromethods (2025), pp. 315-328
Closed Access
COMPARATIVE ANALYSIS OF THE TOTAL PROTEOME IN NONALCOHOLIC STEATOHEPATITIS: IDENTIFICATION OF POTENTIAL BIOMARKERS
Eda Ates, Hien Thi My Ong, Seung-Min Yu, et al.
Molecular & Cellular Proteomics (2025), pp. 100921-100921
Open Access
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1778-1778
Open Access
Sarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships
В. А. Ахмедов, V. S. Marinenko
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 110-118
Closed Access
The Story of Ammonia in Liver Disease: An Unraveling Continuum
Anil C. Anand, Subrat Kumar Acharya
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 4, pp. 101361-101361
Closed Access | Times Cited: 4
A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach
Marica Meroni, Miriam Longo, Erika Paolini, et al.
Journal of Advanced Research (2024) Vol. 68, pp. 231-240
Open Access | Times Cited: 3
Multiomics Picture of Obesity in Young Adults
Olga I. Kiseleva, Mikhail A. Pyatnitskiy, Viktoriia A. Arzumanian, et al.
Biology (2024) Vol. 13, Iss. 4, pp. 272-272
Open Access | Times Cited: 3
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight
Anqi Li, Rui Wang, Yu-Qiang Zhao, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 325-325
Open Access | Times Cited: 3
l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome
Ali Canbay, Oliver Götze, Özlem Kücükoglu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 506-506
Open Access | Times Cited: 2
Mitochondrial targets in hyperammonemia: Addressing urea cycle function to improve drug therapies
Marco F. Moedas, Ricardo Jorge Simões, M. F. B. Silva
Biochemical Pharmacology (2024) Vol. 222, pp. 116034-116034
Open Access | Times Cited: 2
Role of ammonia and glutamine in the pathogenesis and progression of metabolic dysfunction‐associated steatotic liver disease: A systematic review
Basile Njei, Yazan A. Al‐Ajlouni, Prince A. Ameyaw, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 9, pp. 1788-1808
Closed Access | Times Cited: 2
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation
Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M. Landau, et al.
JHEP Reports (2023) Vol. 6, Iss. 3, pp. 100992-100992
Open Access | Times Cited: 4
Adipose tissue-derived stem cells, in vivo and in vitro models for metabolic diseases
Jaime Navarro-Perez, Stefania Carobbio
Biochemical Pharmacology (2024) Vol. 222, pp. 116108-116108
Open Access | Times Cited: 1
The liver–brain axis in metabolic dysfunction-associated steatotic liver disease
Anne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard, Anthony H.V. Schapira, et al.
˜The œLancet. Gastroenterology & hepatology (2024)
Closed Access | Times Cited: 1
Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD
Charalambos Fotakis, Ioanna Panagiota Kalafati, Athina I. Amanatidou, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Huang Zhen mycoplasm polysaccharides mitigate nonalcoholic fatty liver disease induced by a high-fat diet in mice: Evidence from hepatic metabolomics
Yulong Wu, Fufei Xu, Zhaoran Song, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132889-132889
Closed Access
Down the road towards hepatic encephalopathy. The elusive ammonia– what determines the arterial concentration?
Peter Ott, Peter Lykke Eriksen, Kristoffer Kjærgaard, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Open Access
Clinical significance and possibilities for correction of hyperammonemia in patients with atrial fibrillation
An Pan, I. V. Zaikova-Khelimskaia, С. А. Алексеенко
Bulletin physiology and pathology of respiration (2024), Iss. 92, pp. 85-92
Open Access
Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis
Oliver Tavabie, Jane Abbott, Kushala Abeysekera, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 4, pp. e165-e167
Open Access | Times Cited: 1
Efeito da redução da expressão por vírus adeno-associado do receptor de estrogênio alfa sobre o metabolismo hepático
Felipe Sanches Edaes
(2023)
Open Access
Hyperammonemia as a manifestation of post-covid syndrome in patients with nonalcoholic fatty liver disease: post-hoc analysis of the LIRA - COVID observational clinical program
Л. Б. Лазебник, С. В. Туркина, R. G. Myazin, et al.
Experimental and Clinical Gastroenterology (2023), Iss. 12, pp. 140-147
Closed Access
Page 1

Scroll to top